G Brandon Gunn1, Banu Atalar2, Tito R Mendoza3, Charles S Cleeland3, Uğur Selek4, Enis Özyar2, David I Rosenthal1. 1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA. 2. Department of Radiation Oncology, Acıbadem University School of Medicine, İstanbul, Turkey. 3. Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Texas, USA. 4. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA; Department of Radiation Oncology, Koç University School of Medicine, İstanbul, Turkey.
Abstract
BACKGROUND: The use of patient symptom reports with frequent symptom assessment may be preferred over the more commonly used health-related quality of life questionnaires. AIMS: We sought to linguistically validate the Turkish version of the M.D. Anderson Symptom Inventory-Head and Neck module (MDASI-HN) patient reported outcome questionnaire. STUDY DESIGN: Validation study. METHODS: Following standard forward and backward translation of the original and previously validated English MDASI-HN into a Turkish version (T-MDASI-HN), it was administered to patients with head and neck cancer able to read and understand Turkish. Patients were then cognitively debriefed to evaluate their understanding and comprehension of the T-MDASI-HN. Individual and group responses are presented using descriptive statistics. RESULTS: Twenty-six participants with head and neck cancer completed the T-MDASIHN and accompanying cognitive debriefing. Overall, 97 percent of the individual TMDASI-HN items were completed. Average recorded time to complete the 28 item TMDASI-HN questionnaire was 5.4 minutes (range 2-10). Average overall ease of completion, understandability, and acceptability were favorably rated at 1.0, 1.1, and 0.2, respectively, on scales from 0 to 10. Only 5 of the 26 of participants reported trouble completing any single questionnaire items, namely the "difficulty remembering" item for 3 individuals. CONCLUSION: The T-MDASI-HN is linguistically valid with ease of completion, relevance, comprehensibility, and applicability and it can be a useful clinical and research tool.
BACKGROUND: The use of patient symptom reports with frequent symptom assessment may be preferred over the more commonly used health-related quality of life questionnaires. AIMS: We sought to linguistically validate the Turkish version of the M.D. Anderson Symptom Inventory-Head and Neck module (MDASI-HN) patient reported outcome questionnaire. STUDY DESIGN: Validation study. METHODS: Following standard forward and backward translation of the original and previously validated English MDASI-HN into a Turkish version (T-MDASI-HN), it was administered to patients with head and neck cancer able to read and understand Turkish. Patients were then cognitively debriefed to evaluate their understanding and comprehension of the T-MDASI-HN. Individual and group responses are presented using descriptive statistics. RESULTS: Twenty-six participants with head and neck cancer completed the T-MDASIHN and accompanying cognitive debriefing. Overall, 97 percent of the individual TMDASI-HN items were completed. Average recorded time to complete the 28 item TMDASI-HN questionnaire was 5.4 minutes (range 2-10). Average overall ease of completion, understandability, and acceptability were favorably rated at 1.0, 1.1, and 0.2, respectively, on scales from 0 to 10. Only 5 of the 26 of participants reported trouble completing any single questionnaire items, namely the "difficulty remembering" item for 3 individuals. CONCLUSION: The T-MDASI-HN is linguistically valid with ease of completion, relevance, comprehensibility, and applicability and it can be a useful clinical and research tool.
Entities:
Keywords:
Head and neck cancer; Turkish MDASI-HN; patient symptoms; patient-reported questionnaire
Authors: G Brandon Gunn; Tito R Mendoza; Clifton D Fuller; Ibrahima Gning; Steven J Frank; Beth M Beadle; Ehab Y Hanna; Charles Lu; Charles S Cleeland; David I Rosenthal Journal: Head Neck Date: 2012-11-20 Impact factor: 3.147
Authors: David I Rosenthal; Tito R Mendoza; Mark S Chambers; Joshua A Asper; Ibrahima Gning; Merrill S Kies; Randal S Weber; Jan S Lewin; Adam S Garden; K Kian Ang; Xin S Wang; Charles S Cleeland Journal: Head Neck Date: 2007-10 Impact factor: 3.147
Authors: Ethan Basch; Amy P Abernethy; C Daniel Mullins; Bryce B Reeve; Mary Lou Smith; Stephen Joel Coons; Jeff Sloan; Keith Wenzel; Cynthia Chauhan; Wayland Eppard; Elizabeth S Frank; Joseph Lipscomb; Stephen A Raymond; Merianne Spencer; Sean Tunis Journal: J Clin Oncol Date: 2012-10-15 Impact factor: 44.544
Authors: Qiuling Shi; Tito R Mendoza; G Brandon Gunn; Xin Shelley Wang; David I Rosenthal; Charles S Cleeland Journal: Qual Life Res Date: 2013-03-09 Impact factor: 4.147